drugset / Trial / NCT00892892

Sympathetic Nerve Activity in Renal Failure

NCT00892892

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary purpose is to assess the role of sympathetic activation for the development and progression of chronic renal failure. Using microneurography sympathetic activity will be registered in various stages of kidney affection or failure and hypertension. A sympatholytic agent will be compared with a non-sympatholytic drug to asses the effect sympathetic activation and on the progression of kidney disease. The effects of a sympatholytic agent on cardiovascular reactivity to various stressors wil be examined.

Timeline

Start
2009-11
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitrendipine Small molecule 20 mg
Subject Rilmenidine Small molecule 1 mg